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Pseudomyogenic hemangioendothelioma is an extremely rare soft tissue tumor, also named as epithelioid
sarcoma-like hemangioendothelioma, which occurs more frequently in young adult males. It was originally
recognized as a variant of epitheloid sarcoma, however it is now concluded as a distinctive, rarely metastasizing
endothelial neoplasm. We present a case of pseudomyogenic hemangioendothelioma in the lower limb in a
49-year-old female who has a long course of disease and suffered from twice local recurrences and lymph
node affection of the tumor. The mass was subcutaneous and the margins were ill-defined. Morphologically,
the tumor cells show diversity, composed of large spindle cells and round cells, both with abundant eocinophilic
cytoplasm, mimicking rhybdomyoplasts and epitheloid cells respectively. The tumor cells show diffuse strong
expression of Factor VIII, Fli-1, INI-1, vimentin, MDM2, and CDK4, local expression of CD31, AE1/AE3, EMA and P63,
and no expression of CD34, S-100, actin-sm, desmin, MyoD1, and HMB45. Based on these information, this case is
diagnosed as pseudomyogenic hemangioendothelioma after ruling out the main differential diagnosises including
epithelioid sarcoma, malignant peripheral nerve sheath tumor and rhabdomyosarcoma. From this case we suggest that
pseudomyogenic hemangioendothelioma may be confused with a variety of soft tissue neoplasm histologically. The
clinical feature of the case of a long course of disease with twice local recurrences and final lymph node involvement
10 years after excision of the primary tumor indicates a relative indolent behavior of this tumor.Background
Pseudomyogenic hemangioendothelioma, also known as
epithelioid sarcoma-like hemangioendothelioma, occurs
more frequently in young adult males and usually arises
in the extremities, especially on the lower limb, and
often involves multiple tissue planes [1–5]. It histologi-
cally mimics a myoid tumor or epithelioid carcinoma
due to abundant eosinophilic cytoplasm and the cell
shape [1–5]. It is now characterized as a distinctive,
rarely metastasizing endothelial neoplasm [1]. The
tumor is composed of large round or spindle cells, or
commonly both parts, arranged in sheets or fascicles.
The cells rarely show notable pleomorphism or nuclear
atypia [1–3]. Clinically, more than half of the patients
experience local recurrence, and lymph node and distant* Correspondence: wangeh@hotmail.com
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In the case we present here, the patient experienced a
long course of disease and twice recurrences and lymph
node involvement of the tumor after excision of the pri-
mary tumor 10 years ago. Morphologically, the tumor is
composed of both areas of round and spindle cells with
abundant eocinophilic cytoplasm, which may lead to
confusion with a variety of other soft tissue neoplasm
such as epithelioid sarcoma, malignant peripheral nerve
sheath tumor and rhabdomyosarcoma. The immunophe-
notype of expression of INI-1, AE1/AE3, and endothelial
markers such as Factor VIII, Fli-1 and CD31, and nega-
tive staining of desmin, MyoD1, and S-100 supports the
diagnosis of pseudomyogenic hemangioendothelioma in
this case.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Clinical history
A 49-year-old female referred to our hospital for recur-
rence of soft tissue tumor with multiple nodules in her
left lower limb. MRI shows that the nodules were sub-
cutaneous at the left calf below the knee and integrated
to a mass about 6 cm × 5 cm. The mass has been grow-
ing up gradually for 2 years without treatment. Before
that, the patient had a primary tumor about 1 cm × 1 cm
in the same location about 10 years ago. The patient
experienced once recurrence with a new mass at the
same location around the incision 2 years after local
excision of the primary one. This new mass grew up to
about 5 cm × 3 cm in 3 years and then the patient
received a second surgery. And now it is the second
recurrence of the tumor and the third time for her to
receive surgery. MRI also detected a subcutaneous mass
about 3.2 cm × 3.4 cm at her left thigh near the inguinal
area this time. Blood test of the patient shows no abno-
mity. The urinary test shows slight high levels of red
blood cells (5.11/HPF), white blood cells (3.09/HPF),
epithelial cells (2.02/HPF) and urea (7.73 mmol/L).
Materials and methods
The resected specimens of the tumor were fixed with
10 % neutralbuffered formalin and embedded in paraffin
blocks. Tissue blocks were cut into 4 μm-thick sections
and the sections were dewaxed in xylene and rehydrated
stepwise in descending ethanol series. Then the sections
were boiled in citrate buffer (pH 6.0) within an auto-
clave. Endogenous peroxidase activity and non-specific
binding were blocked with 3 % H2O2 and non-immune
sera, respectively. The sections were then incubated with
the following primary antibodies: actin-sm (1:50,
DAKO), AE1/AE3 (1:50, DAKO), CD31 (1:100, DAKO),
CD34 (1:100, DAKO), cytokeratin 18 (CK18, 1:200,
DAKO), cytokeratin 19 (CK19, 1:200, DAKO), CDK4
(1:50, Abcam), desmin (1:50, DAKO), EMA (1:100,
DAKO), Fli-1 (1:100, Abcam), Factor VIII (1:100,
Abcam), HMB45 (1:50, Abcam), INI-1 (1:100, Santa
Cruz), Ki67 (1:200, DAKO), Melan-A (1:50, DAKO),
myoD1 (1:50, DAKO), MDM2 (1:50, Abcam), P63
(1:100, DAKO), S-100 (1:50, DAKO), and vimentin
(1:200, DAKO) overnight at 4 °C. Thereafter, the cata-
lyzed signal amplification system (Maixin Biotechnology,
Fuzhou, Fujian, China) was used for staining of these
proteins according to the manufacturer’s instructions.
The antibodies were detected by a standard avidin-biotin
complex method with biotinylated secondary antibodies
(Maixin) and an avidin-biotin complex (Maixin), and
developed with diaminobenzidine. Counterstaining was
done lightly with hematoxylin, and the sections were
dehydrated in alcohol before mounting. This study was
prospectively performed and approved by the institutionalEthics Committees of China Medical University and con-
ducted in accordance with the ethical guidelines of the
Declaration of Helsinki.Results
Gross features
The resected samples inspected include nodules from
the left calf and thigh of the patient. The masses are
subcutaneous with multiple nodules integrated with
each other and the margins are ill-defined. The mass
from the calf is about 5.5 cm × 4.2 cm × 2.5 cm, and the
one from the thigh is about 3.0 cm × 3.0 cm × 2.5 cm.
The cut surface of the masses is firm, and grey and
yellowish white. MRI shows multiple subcutaneous
nodules at the left calf below the knee integrating to a
mass about 6 cm × 5 cm. The biggest one was about
1.4 cm × 0.9 cm (Fig. 1a, T1-weighted image shows low
signal intensity; 1B, T2-weighted image (STIR) shows
high signal intensity). MRI also detected a subcutane-
ous mass about 3.2 cm × 3.4 cm at the left thigh near
the inguinal area (Fig. 1c, T1-weighted image shows
low signal intensity; 1D, T2-weighted image (STIR)
shows high signal intensity).Microscopic features
The tumor cells are diffusely distributed between the
subcutaneous tissues with an invasive growth pattern
and ill-defined (Fig. 2a). Most of the tumor tissues are
cellular, and a few areas of the tumor have myxoid
stroma and scattered tumor cells (Fig. 2b, c, d). The
tumor cells are round or spindle in different areas, both
with abundant eocinophilic cytoplasm, arranged in
sheets, fascicles or irregularly (Fig. 2b, c, d, e, f ). The
tumor cells are large and plump, but show no apparent
pleomorphism. The nuclei of the cells are also plump
with small nucleoli without notable atypia and the
mitotic activity is scarce (Fig. 2e, f ). The microscopic
features of the primary tumor were the same as the
recurrent tumor (Fig. 2g, h). The microscopic feature of
the mass from the left thigh indicates lymph node
metastasis of the tumor (Fig. 3).Immunophenotype
Immunohistochemical examination indicates that the
tumor cells were diffusely positive for Factor VIII, Fli-1,
CDK4, INI-1, MDM2, vimentin, focally positive for AE1/
AE3, CD31 and negative for actin-sm, CD34, desmin,
myoD1 and S-100 (Fig. 4). Ki67 index was about 5 %
(Fig. 4). In addition, EMA and P63 expression was focal,
CK18, CK19, HMB45 and melan-A were negative in the
tumor cells. The primary tumor also shows a typical Fli-1
and INI-1 positive immunostaining phenotype (Fig. 5).
Fig. 1 The imaging (MRI) of the tumor. MRI shows multiple subcutaneous nodules at the left calf below the knee integrating to a mass about
6 cm × 5 cm. The biggest one was about 1.4 cm × 0.9 cm. (a, T1-weighted image shows low signal intensity, ; b, T2-weighted image (STIR)
shows high signal intensity, ). MRI also detected a subcutaneous mass about 3.2 cm × 3.4 cm at the left thigh near the inguinal area
(c, T1-weighted image shows low signal intensity, ; d, T2-weighted image (STIR) shows high signal intensity, )
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Pseudomyogenic hemangioendothelioma, also named as
epithelioid sarcoma-like hemangioendothelioma, which
morphologically mimics a myoid tumor or epithelioid car-
cinoma, is now concluded as a distinctive, rarely metasta-
sizing endothelial neoplasm [1–5]. This tumor occurs
more frequently in young adult males and usually arises in
the extremities [1–5]. In the case we presented here, the
patient was a 49-year-old female who had a long course of
disease about 10 years with this tumor in her lower limb.
The tumor is composed of large spindle cells, arranged
in sheets or fascicles. Tumor cells with epithelioid cyto-
morphology are also often present [1–5]. In this case,
the tumor is subcutaneous and both areas with spindle
cells and round epithelioid cells exist. The cells are large
and have abundant eosinophilic cytoplasm, mimicking a
myoid tumor or epithelioid carcinoma cells. The tumor
cells are plump, but show no apparent pleomorphism.
The nuclei of the cells have small nucleoli withoutnotable atypia and the mitotic activity is scarce. Based
on these information, the main differential diagnosises
should include epithelioid sarcoma, malignant peripheral
nerve sheath tumor and rhabdomyosarcoma. Epithelioid
sarcoma is a mesenchymal neoplasm exhibiting epitheli-
oid cytomorphology, the classic subtype of which often
occurs in the extremity [1]. Spindle tumor cells can also
present in this tumor. The cell pleomorphism and
nuclear atypia are not notable usually in this tumor
either. However classic epithelioid sarcoma usually con-
sists of cellular node with central degeneration which is
not seen in this case though it cannot be ruled out only
based on this feature. The tumor cells in this case exhibit
abundant eosinophilic cytoplasm mimicking myoid tumor.
Thus rhabdomyosarcoma or leiomyosarcoma should also
be considered. Leiomyosarcoma is a malignant neoplasm
exhibiting pure smooth-muscle differentiation [1]. The
tumor consists mainly of spindle sells arranged in fasci-
cles. However epithelioid cytomorphology can also
Fig. 2 Morphological features of the tumor. Ill-defined tumor cells are diffusely distributed between the subcutaneous tissues (a,×100). Most of
the tumor tissues are cellular with large plump spindle cells (b,×200) or round cells (c,×200). Some areas of the tumor have myxoid stroma and
scattered small round tumor cells (d,×200). The tumor cells are spindle (e,×100) or round (f,×400) in different areas, both with abundant eocinophilic
cytoplasm. The tumor cells are large and plump, showing no apparent pleomorphism. The nuclei of the tumor cells have small nucleoli
without notable atypia and the mitotic activity is scarce (e, f,×400). The microscopic features of the primary tumor were the same as the
recurrent tumor (g, ×100; h,×400)
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is generally notable in leiomyosarcoma which was not
seen in this case. There are several subtypes of rhabdo-
myosarcoma, among which spindle cell/sclerosing
rhabdomyosarcoma is the most important to be differ-
entiated for this case. This subtype has spindle cell
morphology with eosinophilic cytoplasm and shows a
fascicular or plaxiform growth pattern [1]. Epithelioid cells
are rare and nuclear atypia is common in this subtype,
which is different from this case. Malignant peripheralnerve sheath tumor is a malignant tumor arising from
peripheral nerves, which mostly arises in the extremities
[1]. Typical type of this tumor consists of spindle cells
showing a fascicular growth pattern. However there is also
an epithelioid subtype of this tumor composed of epitheli-
oid cells with abundant eosinophilic cytoplasm, which
should also be considered for this case. The neoplasmic
cells of this type are cohesive together or scattered and
embedded in the extracellular myxoid matrix. The similar
areas also exist in this case. However prominent nucleoli
Fig. 3 Lymph node metastasis of the tumor in the thigh far from the primary lesion of the recurrenct tumor and the original tumor. The large
round epithelioid tumor cells are similar in shape to those in the tumor from the lower limb of the patient (a × 100; b × 200)
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this case. Moreover areas with spindle cells are also main
parts of the tumor in this case which is not usual in the
epithelioid subtype of malignant peripheral nerve sheath
tumor. However, a variety of complicated and similarFig. 4 Immunohistochemical staining of the tumor. Fli-1 in tumor cells w
endothelial cells. CD31 was focally positive. INI-1 expression was retained
was very weak or absent compared to endothelial cells. Vimentin was stro
MDM2 and CDK4 were strongly and diffusely positive. Ki67 index was abohistological features can present in all these tumors and
the microscopic features could not be the only basis for
differentiation for these tumors.
In the current case, immunohistochemical examin-
ation shows that the tumor cells were diffusely positiveas diffusely positive and the staining was strong as well as in the
. AE1/AE3 staining was focal and not very strong. CD34 in tumor cells
ngly and diffusely positive. Desmin, S-100 and myoD1 were negative.
ut 5 %
Fig. 5 Immunohistochemical staining of the primary tumor. It also shows a typical immunostaining phenotype of positive Fli-1 and INI-1 expression as
the recurrent tumor
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focally positive for CD31. However these markers are
not absolutely specific for endothelial cells. The other
mesenchymal tumors mentioned above should be ruled
out. INI-1 expression has been found to be lost in some
tumors including epithelioid sarcoma [1]. In this case
INI-1 expression was retained. The myoid tumor
markers such as actin-sm and desmin were negative in
this case. S-100, a marker usually positive in tumors
arising from nervous system including malignant periph-
eral nerve sheath tumor, was also negative in this case.
However even in malignant peripheral nerve sheath
tumor, S-100 expression is not always detected [1]. We
need to differentiate theses tumors more carefully
based on more information but not only on one marker
like S-100. vimentin was diffusely positive in the tumor
cells, which supports but cannot fully prove the tumor
as a mesenchymal neoplasm. As for keratins, AE1/AE3
was focally but not diffusely positive in this case. AE1/
AE3 was usually positive in cases of pseudomyogenic
hemangioendothelioma reported so far [1–5, 10–14].
Some documents mentioned that the immunostaining
pattern is diffuse. However the documents are limited
and more cases are still in need to be studied to verify the
immunostaining pattern of this marker. CD34 expression
is usually negative in pseudomyogenic hemangioendothe-
lioma, however a report indicates that it was positive in
some cases [3]. In a word, the immunophenotype of this
tumor is still to be studied and characterized. From these
information it may be more reasonable to considere this
case as an endothelial neoplasm but not myoid tumor,
peripheral nerve sheath tumor, or epithelioid sarcoma.
Ki67 index in this case was about 5 % and not very high.
MDM2 and CDK4 overexpression are not usually seen in
benign tumors but quite common in intermediate or ma-
lignant mesenchymal tumors [15, 16] and was diffusely
positive in this case. These three markers are helpful to
understand the nature of the tumor and support theconsideration of it as a tumor with a certain extent of ma-
lignant potentials.
However, the histological feature and immuostaining
findings are not enough for fully understanding and
characterizing the tumor of this case as usual. The clin-
ical feature is important for the diagnosis and should be
carefully studied as always. The patient of this case had
experienced a long course of disease with the tumor
about 10 years which indicates the tumor is relative indo-
lent. Approximately 60 % of patients with pseudomyo-
genic hemangioendothelioma experience local recurrence
of the tumor [1]. In this case the patient experienced twice
local recurrences at the same location after local excisions.
After 10 years the tumor has developed a regional sub-
cutaneous lymph node metastasis in her thigh. No distant
metastasis in other organs was found in this patient. Pseu-
domyogenic hemangioendothelioma is now concluded as
a intermediate, rarely metastasizing endothelial neoplasm.
The clinical feature of this patient is also in accordance
with that of pseudomyogenic hemangioendothelioma.
Cancer can be caused by various factors including in-
flammation which can promote the formation of pre-
malignant lesions and promote cancer progression. The
immune system plays complicated roles in the progres-
sion of malignant tumors [17]. In this case, the patient
experienced a couple times of recurrence and at last de-
veloped lymph node metastasis. However, there wasn’t
any clue of inflammation or auto-immune diseases re-
lated found in this patient. So far, the pathogenesis and
mechanism involved in the progression of this tumor is
not uncovered.
Conclusion
Pseudomyogenic hemangioendothelioma is a rare endo-
thelial neoplasm which often mimics myoid and epitheli-
oid tumors morphologically. A variety of mesenchymal
neoplasms with similar architecture and cell morphology
should be carefully differentiated from this tumor. For the
Fan et al. Diagnostic Pathology  (2015) 10:150 Page 7 of 7diagnosis the immunostaining is very important but not
decisive and enough. Clinical information including age,
gender, tumor location, disease course and recurrence is
important for appropriate diagnosis and fully understand-
ing of the tumor and is indispensable. Analysis based on
any single factor or incomplete information may easily
lead to arbitrary conclusion. However the reports of this
tumor are limited. Further studies on more cases are in
need for fully understanding and appropriate diagnosis
of it.
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